These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 26120866

  • 1. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T, Gillmore JD, Wechalekar AD, Hawkins PN, Lachmann HJ.
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [Abstract] [Full Text] [Related]

  • 2. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
    Miyagawa I, Nakayamada S, Saito K, Hanami K, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y.
    Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016
    [Abstract] [Full Text] [Related]

  • 3. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN.
    Lancet; 2001 Jul 07; 358(9275):24-9. PubMed ID: 11454373
    [Abstract] [Full Text] [Related]

  • 4. Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever.
    Yilmaz S, Cinar M, Simsek I, Erdem H, Pay S.
    Rheumatology (Oxford); 2015 Mar 07; 54(3):564-5. PubMed ID: 25504961
    [No Abstract] [Full Text] [Related]

  • 5. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Kumon Y, Hirata S, Takaoka H.
    Clin Exp Rheumatol; 2014 Mar 07; 32(4):501-8. PubMed ID: 24959698
    [Abstract] [Full Text] [Related]

  • 6. AA amyloidosis - Benefits and prospects of IL-6 inhibitors.
    Okuda Y.
    Mod Rheumatol; 2019 Mar 07; 29(2):268-274. PubMed ID: 30132351
    [Abstract] [Full Text] [Related]

  • 7. AA amyloidosis treated with tocilizumab: case series and updated literature review.
    Courties A, Grateau G, Philippe P, Flipo RM, Astudillo L, Aubry-Rozier B, Fabreguet I, Fahd W, Fain O, Guggenbuhl P, Hachulla E, Papo T, Richez C, Sibilia J, Morel J, Berenbaum F, Sellam J, Club Rhumatismes Inflammation and the REGATE Registry.
    Amyloid; 2015 Mar 07; 22(2):84-92. PubMed ID: 25585627
    [Abstract] [Full Text] [Related]

  • 8. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
    Okuda Y, Takasugi K.
    Arthritis Rheum; 2006 Sep 07; 54(9):2997-3000. PubMed ID: 16947531
    [Abstract] [Full Text] [Related]

  • 9. Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis.
    Almenara-Tejederas M, Alonso-García F, Aguillera-Morales WA, de la Prada-Álvares F, Salgueira-Lazo M.
    Nefrologia (Engl Ed); 2022 Sep 07; 42(1):28-32. PubMed ID: 36153896
    [Abstract] [Full Text] [Related]

  • 10. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.
    Ugurlu S, Hacioglu A, Adibnia Y, Hamuryudan V, Ozdogan H.
    Orphanet J Rare Dis; 2017 May 30; 12(1):105. PubMed ID: 28558744
    [Abstract] [Full Text] [Related]

  • 11. Natural history and outcome in systemic AA amyloidosis.
    Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN.
    N Engl J Med; 2007 Jun 07; 356(23):2361-71. PubMed ID: 17554117
    [Abstract] [Full Text] [Related]

  • 12. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A, Zake T, Groma V, Ostrovskis E, Skuja S, Pokrotnieks J.
    J Gastrointestin Liver Dis; 2013 Sep 07; 22(3):333-6. PubMed ID: 24078992
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab.
    Serelis J, Christaki S, Skopouli FN.
    Clin Exp Rheumatol; 2015 Sep 07; 33(6 Suppl 94):S169. PubMed ID: 25572486
    [No Abstract] [Full Text] [Related]

  • 15. Secondary, AA, Amyloidosis.
    Papa R, Lachmann HJ.
    Rheum Dis Clin North Am; 2018 Nov 07; 44(4):585-603. PubMed ID: 30274625
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
    Yamada Y, Ueno T, Irifuku T, Nakashima A, Doi S, Ichinohe T, Masaki T.
    Clin Nephrol; 2018 Sep 07; 90(3):232-236. PubMed ID: 29701172
    [Abstract] [Full Text] [Related]

  • 18. Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports.
    Fukuda M, Sawa N, Hoshino J, Ohashi K, Motoaki M, Ubara Y.
    Clin Nephrol; 2021 Jan 07; 95(1):54-61. PubMed ID: 33155543
    [Abstract] [Full Text] [Related]

  • 19. Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review.
    Giannese D, Ferro F, Moriconi D, Bonadio AG, Elefante E, Egidi MF, Cupisti A, Baldini C.
    CEN Case Rep; 2021 Feb 07; 10(1):23-29. PubMed ID: 32681397
    [Abstract] [Full Text] [Related]

  • 20. AA amyloidosis complicating the hereditary periodic fever syndromes.
    Lane T, Loeffler JM, Rowczenio DM, Gilbertson JA, Bybee A, Russell TL, Gillmore JD, Wechalekar AD, Hawkins PN, Lachmann HJ.
    Arthritis Rheum; 2013 Apr 07; 65(4):1116-21. PubMed ID: 23280696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.